Effects and mechanisms of silibinin on human hepatoma cell lines.
John J. Lah,Wei Cui,Ke-Qin Hu +2 more
Reads0
Chats0
TLDR
It is demonstrated that silibinin significantly reduced the growth of HuH7, HepG2, Hep3B, and PLC/PRF/5 human hepatoma cells and increased acetylation of histone H3 and H4, indicating a possible role of altered histone acetylations in silib inin-reduced HCC cell proliferation.Abstract:
AIM: To investigate in vitro effects and mechanisms of silibinin on hepatocellular carcinoma (HCC) cell growth.
METHODS: Human HCC cell lines were treated with different doses of silibinin. The effects of silibinin on HCC cell growth and proliferation, apoptosis, cell cycle progression, histone acetylation, and other related signal transductions were systematically examined.
RESULTS: We demonstrated that silibinin significantly reduced the growth of HuH7, HepG2, Hep3B, and PLC/PRF/5 human hepatoma cells. Silibinin-reduced HuH7 cell growth was associated with significantly up-regulated p21/CDK4 and p27/CDK4 complexes, down-regulated Rb-phosphorylation and E2F1/DP1 complex. Silibinin promoted apoptosis of HuH7 cells that was associated with down-regulated survivin and up-regulated activated caspase-3 and -9. Silibinin's anti-angiogenic effects were indicated by down-regulated metalloproteinase-2 (MMP2) and CD34. We found that silibinin-reduced growth of HuH7 cells was associated with increased activity of phosphatase and tensin homolog deleted on chromosome ten (PTEN) and decreased p-Akt production, indicating the role of PTEN/PI3K/Akt pathway in silibinin-mediated anti-HCC effects. We also demonstrated that silibinin increased acetylation of histone H3 and H4 (AC-H3 and AC-H4), indicating a possible role of altered histone acetylation in silibinin-reduced HCC cell proliferation.
CONCLUSION: Our results defined silibinin's in vitro anti-HCC effects and possible mechanisms, and provided a rationale to further test silibinin for HCC chemoprevention.read more
Citations
More filters
Journal ArticleDOI
Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.
TL;DR: It is emphasized how increased understanding of the chemopreventive effects of dietary polyphenols on specific epigenetic alterations may provide unique and yet unexplored novel and highly effective chemopresventive strategies for reducing the health burden of cancer and other diseases in humans.
Journal ArticleDOI
Multitargeted therapy of cancer by silymarin.
TL;DR: The protective effects of silymarin and its major active constituent, silibinin, studied in various tissues, suggest a clinical application in cancer patients as an adjunct to established therapies, to prevent or reduce chemotherapy as well as radiotherapy-induced toxicity.
Journal ArticleDOI
Silybin and the liver: From basic research to clinical practice
Carmela Loguercio,Davide Festi +1 more
TL;DR: A review of available studies on the effects of the purified product silybin on liver cells or on experimentally induced liver damage, and in patients with liver disease indicates that the bioavailability of slybin phytosome is higher than that of silymarin and is less influenced by liver damage.
Journal ArticleDOI
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
TL;DR: The aim of this review is to examine scientific studies concerning the effects derived from silymarin/silybin use in chronic liver diseases, cirrhosis and hepatocellular carcinoma.
Journal ArticleDOI
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
Gagan Deep,Rajesh Agarwal +1 more
TL;DR: Detailed mechanistic analyses revealed that silibinin targets signaling molecules involved in the regulation of epithelial-to-mesenchymal transition, proteases activation, adhesion, motility, invasiveness as well as the supportive tumor-microenvironment components, thereby inhibiting metastasis.
References
More filters
Journal ArticleDOI
Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
Ryoji Yao,Geoffrey M. Cooper +1 more
TL;DR: The ability of NGF to prevent apoptosis (programmed cell death) was inhibited by wortmannin or LY294002, two specific inhibitors of phosphatidylinositol (Pl)-3 kinase, and cell survival appears to be mediated by a Pl-3 Kinase signaling pathway distinct from the pathway that mediates differentiation.
Journal ArticleDOI
PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?
TL;DR: These findings indicate that PKB is likely to be a hot drug target for the treatment of cancer, diabetes and stroke, and there are a number of pitfalls of methodologies currently employed to study PKB function, and therefore caution should be used in interpretation of such experiments.
Journal ArticleDOI
PI3K-Akt pathway: its functions and alterations in human cancer.
TL;DR: Specific inhibition of the activation of Akt may be a valid approach to treating human malignancies and overcoming the resistance of cancer cells to radiation or chemotherapy.
Journal ArticleDOI
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
TL;DR: It is raised the possibility that drugs targeting these kinases, or PI3K itself, might have significant therapeutic activity in PTEN-null cancers and phase I and phase II trials of inhibitors of mTOR are underway.
Journal ArticleDOI
Histone deacetylases, transcriptional control, and cancer.
W. Douglas Cress,Edward Seto +1 more
TL;DR: A key event in the regulation of eukaryotic gene expression is the posttranslational modification of nucleosomal histones, which converts regions of chromosomes into transcriptionally active or inactive chromatin.